🇺🇸 Irinotecan Injection in United States

41 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 8 reports (19.51%)
  2. Dehydration — 5 reports (12.2%)
  3. Haemoglobin Decreased — 4 reports (9.76%)
  4. Hyponatraemia — 4 reports (9.76%)
  5. Nausea — 4 reports (9.76%)
  6. Vomiting — 4 reports (9.76%)
  7. Drug Interaction — 3 reports (7.32%)
  8. Drug Toxicity — 3 reports (7.32%)
  9. Neutropenia — 3 reports (7.32%)
  10. Pulmonary Embolism — 3 reports (7.32%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Irinotecan Injection approved in United States?

Irinotecan Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Irinotecan Injection in United States?

Chinese Academy of Medical Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.